We are live on ! Find out more
HVC

Healthcare Value Capital Portfolio holdings

AUM $50.7M
1-Year Est. Return 24.72%
This Fund
S&P 500
This Quarter Est. Return
-0.42%
1 Year Est. Return
+24.72%
3 Year Est. Return
+18.99%
5 Year Est. Return
+98.49%
10 Year Est. Return
–
AUM
$58.5M
AUM Growth
-$34.9M
Cap. Flow
-$13.5M
Cap. Flow %
-23.16%
Top 10 Hldgs %
85.17%
Holding
24
New
4
Increased
–
Reduced
3
Closed
5

Top Buys

Rank Stock Value
1
LAB icon
Standard BioTools
LAB
+$1.74M

Top Sells

Rank Stock Value
1
ANIP icon
ANI Pharmaceuticals
ANIP
+$9.09M
2
AMGN icon
Amgen
AMGN
+$3.65M
3
ARLZ
Aralez Pharmaceuticals Inc.
ARLZ
+$2.54M

Sector Composition

Rank Sector Weight
1 Healthcare 73.69%
2 Miscellaneous 26.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVLN
1
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$8.93M 15.27%
831,440
– –
PFE icon
2
Pfizer
PFE
$160B
$8.55M 14.63%
263,500
– –
SPY icon
3
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$827B
$5.89M 10.08%
25,000
-75,000
-75% -$17.4M
GILD icon
4
Gilead Sciences
GILD
$185B
$5.09M 8.71%
75,000
– –
ASRT
5
DELISTED
Assertio
ASRT
$4.39M 7.51%
5,833
– –
AMRI
6
DELISTED
Albany Molecular Research Inc
AMRI
$4.24M 7.26%
302,400
– –
GILD icon
7
CALL
Gilead Sciences
GILD
$185B
$4.08M 6.97%
60,000
– –
AGN
8
DELISTED
Allergan plc
AGN
$3.58M 6.13%
15,000
– –
IPXL
9
CALL
DELISTED
Impax Laboratories, Inc.
IPXL
$2.53M 4.33%
+200,000
New +$2.42M
AORT icon
10
Artivion
AORT
$1.3B
$2.5M 4.27%
150,000
– –
TEVA icon
11
Teva Pharmaceuticals
TEVA
$43.8B
$2.41M 4.12%
75,000
– –
LAB icon
12
Standard BioTools
LAB
$253M
$1.56M 2.68%
+275,000
New +$1.74M
AMRN
13
Amarin Corp
AMRN
$299M
$1.44M 2.46%
22,500
– –
ASRT
14
CALL
DELISTED
Assertio
ASRT
$1.25M 2.15%
1,667
-2,500
-60% -$2.53M
BIS icon
15
CALL
ProShares UltraShort NASDAQ Biotechnology
BIS
$1.77M
$695K 1.19%
3,125
-3,125
-50% -$737K
IMMU
16
CALL
DELISTED
Immunomedics Inc
IMMU
$647K 1.11%
+100,000
New +$507K
ZGNX
17
DELISTED
Zogenix, Inc.
ZGNX
$346K 0.59%
31,850
– –
LAB icon
18
CALL
Standard BioTools
LAB
$253M
$285K 0.49%
+50,000
New +$317K
FCSC
19
DELISTED
Fibrocell Science Inc.
FCSC
$32K 0.05%
3,185
– –
AMGN icon
20
Amgen
AMGN
$236B
– –
-25,000
Closed -$3.65M
ANIP icon
21
ANI Pharmaceuticals
ANIP
$1.69B
– –
-150,000
Closed -$9.09M
VIXY icon
22
CALL
ProShares VIX Short-Term Futures ETF
VIXY
$212M
– –
-234
Closed -$1.59M
VIRX
23
CALL
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
– –
-4,286
Closed -$543K
ARLZ
24
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
– –
-575,000
Closed -$2.54M

Similar funds

C
Castlelake Minneapolis, Minnesota $48.5M AUM 87.77% 1-Year Est. Return
CC
Cedar Capital Barrington, Illinois $54.9M AUM 33.3% 1-Year Est. Return
FCOI
FirstMark Capital OF II New York $44.1M AUM 18.15% 1-Year Est. Return
FCOI
FirstMark Capital OF I New York $43.1M AUM 6.31% 1-Year Est. Return
BI
BCBSM Inc Eagan, Minnesota $42.4M AUM 0.4% 1-Year Est. Return
KC
Kelso & Company New York $42.3M AUM
SCIM
Spring Creek Investment Management Philadelphia, Pennsylvania $42.3M AUM 31.86% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

Healthcare Value Capital's Q1 2017 Portfolio in Review

As of Q1 2017, Healthcare Value Capital held 24 positions worth $58.5M, down 37% from $93.3M the previous quarter. Its ten largest holdings account for 85% of the portfolio.

Healthcare Value Capital withdrew a net $13.5M in Q1 2017, closing 5 positions and reducing 3 holdings. Its most notable exit was ANI Pharmaceuticals, an estimated $9.09M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, up from 62% a quarter earlier, followed by Miscellaneous.

Against the trend, Healthcare Value Capital opened a new position in Standard BioTools worth $1.56M.

  • Healthcare Value Capital's largest Q1 2017 buy was Standard BioTools: 275,000 shares worth $1.56M.
  • Healthcare Value Capital fully exited ANI Pharmaceuticals in Q1 2017, selling an estimated $9.09M.
  • Healthcare Value Capital's ten largest holdings make up 85% of its $58.5M portfolio in Q1 2017.
  • Healthcare Value Capital opened 4 new positions and closed 5 in Q1 2017.
  • Healthcare Value Capital's portfolio value fell 37% quarter-over-quarter to $58.5M.

Based on Healthcare Value Capital's 13F filing for Q1 2017, filed 12 May 2017.